Kidney Week 2026 Early Program On-Demand - Glomerular Diseases: 2026 Update
Availability
On-Demand
Contains (13)
Welcome and Introduction
Evaluation and Management of Patients with ANCA-Positive Serologies
IgA Nephropathy: How Patient Factors Inform Therapeutic Plans
Novel Treatment Options for C3 Glomerulopathy and Membranoproliferative Glomerulonephritis
Advances in B-Cell-Targeted Therapy for Lupus Nephritis
Clinicopathologic Conference 1: Nephritic Syndromes
Four Pillars in the Management of Glomerular Diseases
Diagnosis and Management of Glomerular Diseases During Pregnancy
Renal Amyloidosis: Updates in Typing, Classification, and Treatment Recommendations
Genetics of Focal Segmental Glomerulosclerosis: The Podocyte and Beyond
APOL1-Mediated Kidney Disease: Update on Pathogenesis and Investigational Therapies
Membranous Nephropathy: Novel Target Antigen Discovery and Therapeutic Implications
Clinicopathologic Conference 2: Nephrotic Syndromes
Did you join us in Denver this year?  On-Demand session recordings are already available in your Early Program course. 

Click here to go to your course list where you can access the Early Program, view lecture recordings, share your feedback, and claim continuing education credit by December 17, 2026.

Note: Login required.
Click each header to expand and learn more.

This comprehensive program highlights exciting new developments in glomerular disease mechanisms, diagnostic tools, and novel therapies. Expert clinicians and researchers discuss major mechanistic and clinical trial breakthroughs and their relevance to patient care through focused didactics, case studies, and audience interaction.

The program explores all major glomerular diseases, including IgA nephropathy, membranous glomerulopathy, ANCA-associated vasculitis, lupus nephritis, focal segmental glomerulosclerosis, and amyloidosis, as well as special-interest topics such as C3 glomerulopathy, glomerular diseases during pregnancy, and nonimmunosuppressive therapies for reducing proteinuria. Two engaging clinicopathologic case conferences challenge panelists as they collaborate to solve difficult cases.

Participants gain a better understanding of the major glomerular diseases and become more confident in managing medically complex patients.

Learning Objectives
Upon completion of the program, the participant will be able to:

  • Summarize treatment options, both immunosuppressive and nonimmunosuppressive, for primary and secondary glomerular diseases 
  • Describe high-risk clinicopathologic features of glomerular diseases that indicate a worse prognosis
  • Analyze recent clinical trial results and their implications for patient care
  • Discuss differential diagnoses for nephrotic and nephritic processes

Target Audience

  • Physicians
  • Researchers
  • Medical and Other Trainees
  • Nurses and Nurse Practitioners
  • Pharmacists
  • Physician Assistants
  • Other Health Care Professionals

Commercial Support
Support is provided by an educational grant from Vera Therapeutics, Inc. 

Privacy Policy/Confidentiality

http://www.asn-online.org/terms/privacy.aspx    
    
ASN Medical Disclaimer     
http://www.asn-online.org/terms/medical-disclaimer.aspx

Co-Chair(s)

  • Rupali S. Avasare, MD
  • Kristin Meliambro, MD

A full faculty listing is available here. 

ASN Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ASN requires all individuals in a position to control content for Kidney Week Early Programs to disclose all financial relationships with ineligible companies within the prior 24 months.

All disclosed financial relationships were reviewed by ASN. Any relevant financial relationships with ineligible companies were identified and mitigated prior to the activity. 

View the ASN Disclosure Policy here.

View faculty disclosures here. View planning committee disclosures here.

For a successful viewing experience, the following hardware and software are required:
  • Broadband cable, DSL, or high-speed internet connection
  • Please use the latest version of Google Chrome for the best viewing experience. Mozilla and Safari can also be used; however, Microsoft Edge is not recommended. Please check the ASN auto-detect settings page.
  • 533 MHz or faster processor
  • 512 MB RAM or higher
  • Adobe Reader (free download)
  • Computer which can play MP3 files
  • Apple iPad/iPhone running HTML5
  • Android devices  
Note: If you are experiencing technical difficulties, please contact education@asn-online.org for assistance.